SCHEMBL358754

SCHEMBL358754

[CH2]CCC(C)(C)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11772668 0.80
SCHEMBL58748 0.76 GRM4 (0.45)
SCHEMBL20327 0.72
SCHEMBL108849 0.71
SCHEMBL358618 0.71
SCHEMBL2693553 0.69
SCHEMBL5984121 0.69
SCHEMBL5443031 0.69 GRM4 (0.41)
SCHEMBL14420440 0.69 GRM4 (0.41)
SCHEMBL18748 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 172 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026243-B2 [4,5′]Bipyrimidinyl-6,4′-diamine derivatives as protein kinase inhibitors NOVARTIS AG (CH) 2011-09-27 US claimed
EP-2044036-B1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2011-05-04 EP claimed
US-20110092491-A1 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity NOVARTIS AG (CH) 2011-04-21 US claimed
US-20100234376-A1 [4,5']Bipyrimidinyl-6,4'-Diamine Deriviatives as Protein Kinase Inhibitors NOVARTIS AG 2010-09-16 US claimed
EP-2207852-A1 SILICONE HYDROGELS WITH AMINO SURFACE GROUPS Bausch & Lomb Incorporated (US) 2010-07-21 EP claimed
US-20100056494-A1 PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES IRM LLC (BM) 2010-03-04 US claimed
CN-101622001-A Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases IRM LLC 2010-01-06 CN claimed
EP-2124954-A2 PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES IRM LLC (BM) 2009-12-02 EP claimed
CN-101511798-A [4, 5 '] bipyrimidinyl-6, 4' -diamine derivatives as protein kinase inhibitors IRM LLC (VG) 2009-08-19 CN claimed
WO-2009055226-A1 SILICONE HYDROGELS WITH AMINO SURFACE GROUPS BAUSCH & LOMB INCORPORATED (US) 2009-04-30 WO claimed
WO-2008094737-A2 PURINE COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS FOR THE TREATMENT OF PLASMODIUM RELATED DISEASES IRM LLC (BM) 2008-08-07 WO claimed
WO-2008008747-A1 [4,5']BIPYRIMIDINYL-6,4'-DIAMINE DERIVATIVES AS PROTEIN KINASE INHBITORS IRM LLC (BM) 2008-01-17 WO claimed
CN-1835952-A 6-substituted anilinopurine as RTK inhibitors IRM LLC (BM) 2006-09-20 CN claimed
EP-1656378-A2 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF RECEPTOR TYROSINE KINASE ACTIVITY IRM LLC (BM) 2006-05-17 EP claimed
US-20050124637-A1 Compounds and compositions as inhibitors of receptor tyrosine kinase activity IRM LLC (BM) 2005-06-09 US claimed
WO-2005016528-A2 6-SUBSTITUTED ANILINO PURINES AS RTK INHIBITORS IRM LLC (BM) 2005-02-24 WO claimed
EP-0517843-A1 POLYUREA GEL COMPOSITIONS AND ARTICLES THEREFROM RAYCHEM CORPORATION (US) 1992-12-16 EP claimed
US-5104930-A Sealing and protecting substrates; tensile strength, elongation, toughness, compatibility RAYCHEM CORPORATION (US) 1992-04-14 US claimed
WO-1991013109-A1 POLYUREA GEL COMPOSITIONS AND ARTICLES THEREFROM RAYCHEM CORPORATION (US) 1991-09-05 WO claimed
US-4720548-A Quinoxaline adducts useful as anthelmintics ANGUS CHEMICAL COMPANY (US) 1988-01-19 US claimed